sumi.news
Search
Following
Sign in
← Back to news
Markets
RSS Feed
sumi.news
Markets
Follow
Latest
Tue Jun 2
Mon Jun 1
Here’s What Analysts Are Saying About Royal Bank of Canada (RY) Post Q1
1d
Y
High Earners Are Skipping Treasuries for These 3 Tax Free Muni ETFs Yielding Over 4 Percent After Tax
1d
Y
Jefferies Lifts PT on The Toronto-Dominion Bank (TD) But Maintains a Hold Rating
1d
Y
Mizuho Lifts PT on Arm Holdings plc (ARM) After Analysis of the Memory Market and Impact of Agentic AI
1d
Y
Jefferies Remains Bullish on Palo Alto Networks (PANW)
1d
Y
Bra Sales Power Victoria’s Secret Turnaround and Shares Soar
1d
Y
Eli Lilly and Company’s (LLY) Foundayo and Zepbound Set To Be Covered for Millions of Americans
1d
Y
ICAS members call for income tax and NI reform after Scottish election
1d
Y
GlobalX Airlines accuses shareholder of undermining cargo business
1d
Y
Sheikh Ahmed Dalmook Al Maktoum’s Inmā Emirates Holdings Launches Grant Program To Help Scale Climate Resilience Ventures
1d
Y
Oil market could be underpricing risks, Vitol's Bahrain chief says
1d
Y
Why Pipeline Income Investors Are Betting on Energy Transfer and Enterprise Products
1d
Y
Shake Shack cuts Q2 2026 and full-year guidance on macro uncertainty
1d
Y
Parex Resources completes $500m acquisition of Frontera E&P assets
1d
Y
1 Legally Protected Monopoly Yielding Over 4% That Is Structurally Primed to Make Patient Investors Richer
1d
Y
3 Reasons Cathie Wood's Buying Nvidia Stock This Week
1d
Y
Amcor secures cleanroom certification for Carolina thermoforming site
1d
Y
Is NVIDIA Corporation (NVDA) One of the Best Stocks to Buy Now for Long Term Growth?
1d
Y
AstraZeneca’s (AZN) CARES Phase III Clinical Programme Fails to Meet Primary End Point
1d
Y
Toyota Motor Corporation (TM) Seeks Approval for New Vehicle Assembly Line in Texas, Reuters Reports
1d
Y
TD Securities Remains Bullish on Royal Bank of Canada (RY)
1d
Y
CIBC Lifts PT on The Toronto-Dominion Bank (TD)
1d
Y
Gilead Sciences (GILD) Announces New Results From a Post Hoc Analysis
1d
Y
Merck & Co. (MRK) Announces Quarterly Dividend
1d
Y
Mastercard names Ling Hai CFO, moves Sachin Mehra to new role
1d
Y
Here’s What Analysts Are Saying About Salesforce (CRM)
1d
Y
Is Sandisk Corporation (SNDK) One of the Best Inexpensive Stocks to Invest in Right Now?
1d
Y
Is The Walt Disney Company (DIS) One of the Best Inexpensive Stocks to Invest in Right Now?
1d
Y
Is Micron Technology (MU) One of the Best Inexpensive Stocks to Invest in Right Now?
1d
Y
Chief Risk Officer Sells 11,250 Shares of Regional Insurer, According to Latest SEC Filing
1d
Y
Abivax stock plunges on cancer signal in ulcerative colitis trial
1d
Y
Is Pfizer Inc. (PFE) Expanding Its Cancer Pipeline Through a Landmark Innovent Partnership?
1d
Y
Gilead Sciences, Inc. (GILD) Gains Attention as Livdelzi Demonstrates Long-Term Efficacy and Safety
1d
Y
GSK plc (GSK) Launches Ask2BSure Meningitis Awareness Campaign With Celebrity Advocates
1d
Y
Why Zoetis Inc. (ZTS) Was Downgraded Following Steep Market Selloff?
1d
Y
Why Canaccord Reduced Prestige Consumer Healthcare Inc. (PBH) Price Target After Q4 Weakness
1d
Y
Amphastar Pharmaceuticals, Inc. (AMPH) Price Target Cut to $21 At Piper Sandler Amid Pipeline Uncertainty
1d
Y
Grifols, S.A. (GRFS) Sees Strong Biopharma Growth Led by Gamunex and Yimmugo
1d
Y
Franklin Templeton Taps MoonPay to Bring Stablecoin Cash Into Tokenized Funds
1d
Y
Victoria’s Secret Stock Surges 48% After Earnings. What’s Driving the Gains.
1d
Y
The SpaceX IPO Is Whipping Space Stocks Into a Frenzy
1d
Y
Signet Jewelers Q1 Earnings Call Highlights
1d
Y
Absa gets approval to buy Standard Chartered Uganda assets
1d
Y
The record-setting S&P 500 is putting up some impressive stats: By the numbers
1d
Y
Credo Just Told The Market Something Bigger Than Earnings
1d
S
Salesforce (CRM) Shows Narrative Divergence Amid Anthropic’s Developments
1d
Y
Tech Tuesday: Coppel Teams with First Insight
1d
Y
Netflix Nearing 52-Week Low: Buy, Sell or Hold?
1d
Y
KB (KB) Q1 2026 Earnings Call Transcript
1d
Y
Is Ironwood Pharmaceuticals, Inc. (IRWD) Strengthening Its Growth Outlook With Expanded Pediatric Approval for Linzess?
1d
Y
More →